Dr Lisa ShawClinical Research Associate
Email: lisa.shaw@ncl.ac.uk Telephone: 0191 222 3826 Address: Institute for Ageing and Health
Shaw LC, Price CIM, van Wijck FMJ, Shackley P, Steen N, Barnes MP, Ford GA, Graham LA, Rodgers H. Botulinum Toxin for the Upper Limb After Stroke (BoTULS): TrialEffect on Impairment, Activity Limitation, and Pain .
Stroke 2011, 42 (5), 1371-1379.
Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS Investigators. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A .
Health Technology Assessment 2010, 14 (26), 1-+.
Shaw L, Rodgers H. Botulinum toxin type A for upper limb spasticity after stroke .9 12 1713-1725.
Rodgers H, Shaw L, Price C, Wijck Fvan, Barnes M, Graham L, Ford GA, Shackley P, Steen N. Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A .
Trials 2008, 9 (1), 59.
Shaw L, Price C, McLure S, Howel D, McColl E, Ford GA. Paramedic Initiated Lisinopril for Acute Stroke Treatment (PIL-FAST): study protocol for a pilot randomised controlled trial .
Trials 2011, 12 (1), 152.
Shaw LC, Barnes MP, Rodgers H. Response to Letter by Munin et al Regarding Article, "Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain" .
Stroke 2011, 42 (7), E413.
Shaw L, Rodgers H. Botulinum toxin to treat spasticity after stroke .
Shaw L, Ahmed S, Austin C, Taggart MJ. Inhibitors of Actin Filament Polymerisation Attenuate Force but not Global [Ca2+]i in Isolated Pressurised Resistance Arteries .
Journal of Vascular Research 2003, 40 (1), 1-10.
